Bolt Biotherapeutics, Inc. Common Stock BOLT
$3.29
+2.49%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-08-11 | View → |
| 8-K | 8-K | 2026-08-11 | View → |
| 4 | 4 | 2026-06-11 | View → |
| 4 | 4 | 2026-06-11 | View → |
| 4 | 4 | 2026-06-11 | View → |
| 4 | 4 | 2026-06-11 | View → |
| 4 | 4 | 2026-06-11 | View → |
| 8-K | 8-K | 2026-06-11 | View → |
| 10-Q | 10-Q | 2026-05-12 | View → |
| 8-K | 8-K | 2026-05-12 | View → |
| DEF 14A | DEF 14A | 2026-04-28 | View → |
| 10-K | 10-K | 2026-03-12 | View → |
| 8-K | 8-K | 2026-03-12 | View → |
| 4 | 4 | 2026-02-04 | View → |
| 4 | 4 | 2026-02-04 | View → |
| 4 | 4 | 2026-02-04 | View → |
| 4 | 4 | 2025-12-16 | View → |
| 4 | 4 | 2025-12-16 | View → |
| 4 | 4 | 2025-12-16 | View → |
| 4 | 4 | 2025-12-16 | View → |
| 4 | 4 | 2025-12-16 | View → |
| 4 | 4 | 2025-12-16 | View → |
| 4 | 4 | 2025-12-16 | View → |
| 4 | 4 | 2025-12-16 | View → |
| 10-Q | 10-Q | 2025-11-12 | View → |
| 8-K | 8-K | 2025-11-12 | View → |
| 4 | 4 | 2025-10-24 | View → |
| 4 | 4 | 2025-10-24 | View → |
| 4 | 4 | 2025-10-24 | View → |
| 8-K | 8-K | 2025-10-02 | View → |
| 10-Q | 10-Q | 2025-08-14 | View → |
| 8-K | 8-K | 2025-08-14 | View → |
| 4 | 4 | 2025-07-02 | View → |
| 4 | 4 | 2025-07-02 | View → |
| 4 | 4 | 2025-07-02 | View → |
| 4 | 4 | 2025-07-02 | View → |
| 4 | 4 | 2025-07-02 | View → |
| 8-K | 8-K | 2025-06-06 | View → |
| 8-K | 8-K | 2025-06-04 | View → |
| 8-K | 8-K | 2025-05-28 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $3.29
- Market Cap
- $6.63 million
- 52-Week Range
- $3.13 – $7.20
- Average Volume
- 21K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.